Browse USP24

Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location -
Domain PF00443 Ubiquitin carboxyl-terminal hydrolase
Function

Protease that can remove conjugated ubiquitin from target proteins and polyubiquitin chains. Deubiquitinates DDB2, preventing its proteasomal degradation.

> Gene Ontology
 
Biological Process GO:0016579 protein deubiquitination
GO:0070646 protein modification by small protein removal
Molecular Function GO:0008234 cysteine-type peptidase activity
GO:0019783 ubiquitin-like protein-specific protease activity
GO:0036459 thiol-dependent ubiquitinyl hydrolase activity
GO:0101005 ubiquitinyl hydrolase activity
Cellular Component -
> KEGG and Reactome Pathway
 
KEGG -
Reactome R-HSA-5688426: Deubiquitination
R-HSA-392499: Metabolism of proteins
R-HSA-597592: Post-translational protein modification
R-HSA-5689880: Ub-specific processing proteases
Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between USP24 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 

There is no record.

Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of USP24 in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell logFC: 1.45; FDR: 0.000651 Sensitive to T cell-mediated killing
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell logFC: -2.15; FDR: 0.04220 Resistant to T cell-mediated killing
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR NA/NS NA/NS
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NS NA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NS NA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NS NA/NS
24476824shRNAmelanomaB16Primary screen NA/NS NA/NS
24476824shRNAmelanomaB16Secondary screen NA/NS NA/NS
Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of USP24 in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)14120.1770.499
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)650.40.769
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)870.0180.985
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 916-0.0180.949
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 59-0.1460.956
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470.1460.966
729033130MelanomaallAnti-PD-1 (nivolumab) 26230.2170.564
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 15110.2630.885
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 11120.1760.931
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 480.5090.625
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 281.0640.473
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 68230-0.0150.751
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of USP24 in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14177.15.91.21
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 103100101
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 41407.1-7.11
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 27733.74.1-0.41
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 0140001
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 27593.75.1-1.41
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)21174.804.81
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)860001
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)13117.707.71
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 91606.2-6.21
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590001
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 47014.3-14.31
1329033130MelanomaallAnti-PD-1 (nivolumab) 38275.33.71.61
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 22139.17.71.41
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 16140001
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 11130001
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 5120001
Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of USP24. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of USP24. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by USP24.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of USP24. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of USP24 expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between USP24 and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolUSP24
Nameubiquitin specific peptidase 24
Aliases KIAA1057; ubiquitin specific protease 24; deubiquitinating enzyme 24; ubiquitin thioesterase 24; ubiquitin t ......
Chromosomal Location1p32.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting USP24 collected from DrugBank database.
> Drugs from DrugBank database
 

There is no record.